
- Volume 0 0
Anxiety Disorders Helped by Antipsychotics
A recent data review revealed that theantipsychotic drug trifluoperazine is welltoleratedand more effective than placebofor the short-term treatment of generalizedanxiety disorder. Researchers fromthe University Hospitals of Cleveland/Case Western Reserve University conductedthe review to determine howeffective an antipsychotic drug would bein treating anxiety. Researchers looked atstudies of bipolar disorder and majordepressive disorders that included anxiety-related changes. Keming Gao, MD, PhD, of the review team said, "We foundthat, in a well-designed study, low dosesof trifluoperazine?were well-toleratedand superior to placebo. In less welldesignedstudies, other?antipsychoticsappeared to be superior to placebo andmight be as effective as sedative drugs inthe short-term treatment of generalizedanxiety disorders." Results also showedthat, when compared with placebo, theantipsychotics olanzapine and quetiapinesignificantly reduced symptoms ofanxiety in patients with bipolar disorder.
Articles in this issue
about 19 years ago
compounding HOTLINEabout 19 years ago
The Good and the Bad of High Cholesterolabout 19 years ago
Compounding Dental Applicationsabout 19 years ago
An Overview and Update of the Controlled Substances Act of 1970about 19 years ago
ccpa SPEAKS OUT: AMP Definition "Defines" Pharmacists out of Medicaidabout 19 years ago
Are We Really Ready? Preparing for Disastersabout 19 years ago
When the Patient Won't Take the Medicineabout 19 years ago
Community Commitment Earns RESPy Awardabout 19 years ago
Kerr's Center Concentrates on Health and Educationabout 19 years ago
Mandatory Periodic Breaks for Pharmacists UpheldNewsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


























